Using the primary site as a prognostic tool for nodal mantle cell lymphoma: a SEER-based study.
Conclusion: NMCL primary site can serve as a prognostic factor. We encourage adding it to MCL International Prognostic Index.
PMID: 32885984 [PubMed - as supplied by publisher]
Source: Journal of Comparative Effectiveness Research - Category: General Medicine Tags: J Comp Eff Res Source Type: research
More News: Cancer | Cancer & Oncology | Databases & Libraries | Epidemiology | General Medicine | Lymphoma | Study